Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database
Authors
Keywords
Breast neoplasms, Molecular subtype, Prognosis, Survival analysis, Tamoxifen therapy
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 169, Issue 2, Pages 311-322
Publisher
Springer Nature
Online
2018-01-30
DOI
10.1007/s10549-018-4681-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress
- (2017) Eun Hwa Park et al. Journal of Breast Cancer
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
- (2015) Mathias Worni et al. JNCI-Journal of the National Cancer Institute
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
- (2015) Mathias Worni et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
- (2015) Steven A. Narod et al. JAMA Oncology
- Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis
- (2014) H. Staley et al. BREAST
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24
- (2012) D. Craig Allred et al. JOURNAL OF CLINICAL ONCOLOGY
- Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
- (2011) Aoife J. Lowery et al. BREAST CANCER RESEARCH AND TREATMENT
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
- (2011) I. L. Wapnir et al. JNCI-Journal of the National Cancer Institute
- Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component
- (2010) Ke-Da Yu et al. ANNALS OF SURGICAL ONCOLOGY
- Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society
- (2010) Hyeong-Gon Moon et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Underweight and Breast Cancer Recurrence and Death: A Report From the Korean Breast Cancer Society
- (2009) Hyeong-Gon Moon et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
- (2008) Paul L. Nguyen et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now